PE-001 片治疗成年男性早泄(PE)受试者的有效性、安全性的随机、双盲、安慰剂对
照、多中心 II 期临床试验
[Translation] A randomized, double-blind, placebo-controlled, multicenter Phase II clinical trial to evaluate the efficacy and safety of PE-001 tablets in the treatment of adult male premature ejaculation (PE) subjects
以安慰剂为对照,探索不同剂量 PE-001 片治疗男性早泄受试者的有效性;
[Translation] Using placebo as control, explore the effectiveness of different doses of PE-001 tablets in treating male subjects with premature ejaculation;
MT-1207片治疗轻、中度原发性高血压的有效性和安全性的随机、双盲、安慰剂和阳性药物平行对照、多中心II期临床试验
[Translation] A randomized, double-blind, placebo- and active drug-controlled, multicenter Phase II clinical trial of the efficacy and safety of MT-1207 tablets in the treatment of mild and moderate essential hypertension
MT-1207片治疗轻、中度原发性高血压的有效性和安全性的随机、双盲、安慰剂和阳性药物平行对照、多中心II期临床试验
[Translation] A randomized, double-blind, placebo- and active drug-controlled, multicenter Phase II clinical trial of the efficacy and safety of MT-1207 tablets in the treatment of mild and moderate essential hypertension
评价 MT-1207 在高血压患者中单中心、随机、剂量递增、安慰剂和阳性对照的单次、多次给药的耐受性、药代动力学及药效学的Ⅰb期临床试验
[Translation] A single-center, randomized, dose-escalating, placebo- and active-controlled Phase Ib clinical trial to evaluate the tolerability, pharmacokinetics, and pharmacodynamics of MT-1207 in patients with hypertension
主要目的: 评价 MT-1207 在高血压患者中多剂量、单次、多次给药耐受性; 评价 MT-1207 在高血压患者中多剂量、单次、多次给药药代动力学; 次要目的: 初步评价药效学
[Translation] Primary purpose: To evaluate the tolerability of MT-1207 in patients with hypertension after multiple doses, single doses, and multiple administrations; To evaluate the pharmacokinetics of MT-1207 in patients with hypertension after multiple doses, single doses, and multiple administrations; Secondary purpose: To preliminarily evaluate the pharmacodynamics
100 Clinical Results associated with Liaoning Green Biological Pharmaceutical Group Co., Ltd.
0 Patents (Medical) associated with Liaoning Green Biological Pharmaceutical Group Co., Ltd.
100 Deals associated with Liaoning Green Biological Pharmaceutical Group Co., Ltd.
100 Translational Medicine associated with Liaoning Green Biological Pharmaceutical Group Co., Ltd.